Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy

Abstract

This review explores recent advances in the development of cancer immunotherapy using nanoparticles for tumor vaccine, stimulating tumor specific T cells, and delivering immuno-activation and modulatory agents to activate cytotoxic T cells.